Where clinically appropriate, switching to weight-neutral alternatives should be explored with the prescribing clinician
Evidence suggests that GLP-1 pathways influence the central nervous system via multiple routes: some agents and/or their downstream effects reach or affect the brain and bloodbrain barrier , altering glucose transport, microglial activation, and synaptic function in preclinical and early human studies
In addition, anticipatory, associative and behavioural symptoms such as anxiety and irritability are also observed
Over the past five years, the GLP1 treatment landscape has rapidly evolved
Physicochemical factors that impact oral drug absorption Our group recently investigated the interrelation of physicochemical properties and individual parameters for a database comprised of Fa, Fg, Fh, and F values for 309 drugs in humans (Varma et al
Retrieved from McCarthy, D